We monitored their blood glucose using CGM in their normal environment, and we extensively characterized them with clinical metabolic phenotypes including whole-body insulin resistance and insulin secretion (see Fig 1 and Methods for an overview of the study design). Here, INS is linked to Insulin resistance.